GlassScriptPhysician profile
Jeffrey S Eaton
NPI 1316913650
$6,776.61
in general payments reported to CMS, 2019-2025
40 companies · $976 in 2025
The $976 reported for 2025 was more than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $903 · 2020: $495 · 2021: $1,312 · 2022: $765 · 2023: $916 · 2024: $1,410 · 2025: $976.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,117 · Education: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,116.53 |
| Education | $184.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $802.72 | 2019-2025 | |
| Pfizer INC. | $547.73 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $457.69 | 2020-2025 | Winlevi, Absorica Ld, Ilumya |
| Abbvie INC. | $435.90 | 2021-2025 | Rinvoq, Skyrizi |
| Glaxosmithkline, LLC. | $412.85 | 2023-2025 | Nucala |
| Janssen Biotech, INC. | $404.05 | 2019-2024 | Tremfya, Remicade, Simponi |
| Regeneron Healthcare Solutions, INC. | $374.35 | 2019-2025 | Libtayo, Dupixent |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $369.47 | 2019-2024 | Cabtreo, Jublia, Arazlo |
| Leo Pharma INC. | $363.08 | 2019-2025 | Anzupgo |
| Galderma Laboratories, L.P. | $305.53 | 2019-2025 | Aklief |
| Stryker Corporation | $266.58 | 2019-2025 | Shaver System |
| Amgen INC. | $221.50 | 2019-2025 | Otezla, Otezla |
| Genentech USA, INC. | $207.23 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $194.25 | 2023-2025 | Zoryve |
| Incyte Corporation | $173.17 | 2021-2025 | Opzelura |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $140.30 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $106.00 | 2021 | |
| Almirall LLC | $93.30 | 2019-2021 | |
| Ani Pharmaceuticals, INC. | $84.10 | 2025 | Oxistat, Purified Cortrophin Gel |
| Prugen, INC. Pharmaceuticals | $82.66 | 2020 | |
| Journey Medical Corporation | $70.32 | 2022-2025 | |
| Helsinn Therapeutics (U.S.), INC. | $69.94 | 2022-2025 | Valchlor |
| Ucb, INC. | $59.79 | 2024 | Bimzelx |
| Smith+Nephew, INC. | $56.50 | 2024 | Tula |
| Integra Lifesciences Corporation | $53.84 | 2020-2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Lilly USA, LLC | $53.17 | 2024-2025 | Ebglyss, Taltz |
| Dermavant Sciences, INC. | $44.12 | 2023 | Vtama |
| Intersect Ent, INC. | $38.76 | 2019 | |
| Biofrontera INC. | $36.64 | 2024-2025 | Rhodoled Xl, Xepi, Bf-Rhodoled |
| Revance Therapeutics, INC. | $33.09 | 2024 | Daxxify |
| Vyne Pharmaceuticals INC. | $32.82 | 2021 | |
| Merz North America, INC. | $30.03 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $28.79 | 2022 | |
| Neurent Medical Limited | $25.48 | 2023 | Neuromark Radiofrequency Console, Neuromark Device |
| Acera Surgical, INC. | $22.91 | 2022 | |
| Celgene Corporation | $17.71 | 2019 | |
| Apyx Medical Corporation | $17.61 | 2020 | |
| Mission Pharmacal Company | $15.27 | 2019 | |
| Dermira, INC. | $14.56 | 2021 | |
| Misonix INC | $12.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Eaton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.